In glioblastoma, lactylation of the X-ray Repair Cross Complementing 1 (XRCC1) protein, a key player in DNA repair, enhances its ability to repair DNA damage, thereby contributing to the development of resistance to chemoradiotherapy. Here, XRCC1 is linked to glioblastoma.